The estimated healthcare cost of diabetic retinopathy in Indonesia and its projection for 2025.
Muhammad Bayu SasongkoFirman Setya WardhanaGandhi Anandika FebryantoAngela Nurini AgniSupanji SupanjiSarah Rizqia IndrayantiTri Wahyu WidayantiFelicia WidyaputriIdhayu Anggit WidhasariYeni Dwi LestariGitalisa Andayani AdrionoIwan SovaniArief Sjamsulaksan KartasasmitaPublished in: The British journal of ophthalmology (2019)
The estimated healthcare cost of DR in Indonesia in 2017 was considerably high, nearly 2% of the 2017 national state budget, and projected to increase significantly to more than threefold in 2025. The highest cost may incur for DR requiring both laser and IVT injection. Therefore, public health intervention to delay or prevent severe DR may substantially reduce the healthcare cost of DR in Indonesia.